Published on 12 Jan 2024 on Simply Wall St. via Yahoo Finance
Investors in Alliance Pharma (LON:APH) have unfortunately lost 52% over the last three years
If you love investing in stocks you're bound to buy some losers. Long term Alliance Pharma plc (LON:APH) shareholders know that all too well, since the share price is down considerably over three years. Unfortunately, they have held through a 54% decline in the share price in that time. And the ride hasn't got any smoother in recent times over the last year, with the price 35% lower in that time.
With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.
View our latest analysis for Alliance Pharma